Expression of NKG2D ligands has been shown in tissues from patients with chronic inflammatory diseases, including rheumatoid arthritis (16, 17), type 1 diabetes (18), and atherosclerosis (19); much less is known regarding NKG2D ligand expression and relevance in mucosal epithelia during both normal and stress conditions. This evidence concerns the gene KLRK1 and rheumatoid arthritis.